Utilization And Impact Of Value Assessment Frameworks On Payer Decisions Regarding Chimeric Antigen Receptor T-Cell Therapies
May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.228
https://www.valueinhealthjournal.com/article/S1098-3015(18)30528-X/fulltext
Section Title :
Section Order :
1105
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30528-X&doi=10.1016/j.jval.2018.04.228